The advertisement promotes Kesimpta, highlighting its unique feature as the first and only self-administered B-cell therapy for RMS, while also providing important safety information regarding contraindications.
Creative Information
| CID: | fb51c3e0-fd89-485f-ab33-9602929f6c12 |
| CRID: | 82_5530-783280 |
| Domain: | kesimptahcp.com |
| Seat: | PP |
| Size: | 728x90 |
| Bid: | $0.02 |
| Timestamp: | 11/13/2025, 6:50:30 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/13/2025, 8:27:06 PM | 6.79s | |
| adomain_analysis | success | 11/13/2025, 9:04:45 PM | 3.26s | |
| adomain_capture | success | 11/13/2025, 9:03:10 PM | 0.10s | |
| ad_render | success | 11/13/2025, 8:26:59 PM | 25.82s | |
| brand_mapping | success | 11/13/2025, 6:50:30 PM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: KESIMPTA
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1189.31 KB | ||||||||||||||||||||||
| Render Time: | 10.29 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1189.39 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


